Measurement of Irisin, Adiponectin, and Leptin Levels in Patients with Idiopathic Epilepsy
Bezmialem Science · 26.10.2026
DOI: 10.14235/bas.galenos.2026.77785 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bezmialem Science, online erschienen am 26.10.2026. Verfasst von Şeyma SÖNMEZ ŞAHİN und 7 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Objective
Epilepsy is a common childhood neurological disorder in which neuroinflammatory and metabolic mechanisms may contribute to epileptogenesis. Adipomyokines such as irisin, leptin, and adiponectin have been suggested to influence neuroinflammation, energy metabolism, and neuronal excitability. This study aimed to evaluate serum adipomyokine levels in children with idiopathic epilepsy and investigate their association with treatment response.
Methods
This case-control study included 68 children with idiopathic epilepsy (15 drug-resistant, 53 drug-responsive) and 66 healthy controls. Serum irisin, leptin, and adiponectin levels were measured using ELISA. After one-to-one matching based on body mass index (BMI), age, and sex, 58 epilepsy patients and 58 controls were included in the final analyses. For subgroup analyses, 15 drug-resistant patients were compared with 15 BMI-matched drug-responsive patients. Correlation, logistic regression, and receiver operating characteristic analyses were performed.
Results
After matching, serum irisin levels were significantly lower in epilepsy patients compared to controls (p=0.032). Leptin and adiponectin levels did not differ significantly between epilepsy and control groups. In subgroup analyses, leptin and adiponectin levels were significantly higher in drug-responsive patients than in drug-resistant patients (p=0.043 and p=0.024, respectively). Irisin levels did not differ between epilepsy subgroups. Logistic regression analyses showed that leptin and adiponectin were associated with treatment response.
Conclusion
The findings suggest that irisin may be involved in epilepsy-related mechanisms, whereas leptin and adiponectin may be associated with treatment response. Although adipomyokines appear to have limited diagnostic utility for differentiating epilepsy subtypes, they may represent potential biomarkers for predicting treatment response in pediatric epilepsy.
Zitieren
APA
ŞAHİN, Ş. S., ŞAHİN, T. U., YILDIZ, T., ÇAKIN, Z. E., DURAN, S., SELEK, Ş., İÇAĞASIOĞLU, D. F., & İŞCAN, A. (2026). Measurement of Irisin, Adiponectin, and Leptin Levels in Patients with Idiopathic Epilepsy. Bezmialem Science. https://doi.org/10.14235/bas.galenos.2026.77785
Vancouver
ŞAHİN ŞS, ŞAHİN TU, YILDIZ T, ÇAKIN ZE, DURAN S, SELEK Ş, et al. Measurement of Irisin, Adiponectin, and Leptin Levels in Patients with Idiopathic Epilepsy. Bezmialem Science. 2026. doi:10.14235/bas.galenos.2026.77785
BibTeX
@article{AHN2026,
author = {ŞAHİN, Şeyma SÖNMEZ and ŞAHİN, Türkan UYGUR and YILDIZ, Tuğçe and ÇAKIN, Zeynep Ebru and DURAN, Seher and SELEK, Şahabettin and İÇAĞASIOĞLU, Dilara Füsun and İŞCAN, Akın},
title = {Measurement of Irisin, Adiponectin, and Leptin Levels in Patients with Idiopathic Epilepsy},
journal = {Bezmialem Science},
year = {2026},
doi = {10.14235/bas.galenos.2026.77785}
}
EUVIMED